PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients with Left Ventricular Dysfunction Post STEMI

Arshed A. Quyyumi*, Alejandro Vasquez, Dean J. Kereiakes, Marc Klapholz, Gary L. Schaer, Ahmed Abdel-Latif, Stephen Frohwein, Timothy D. Henry, Richard A. Schatz, Nabil DIb, Catalin Toma, Charles J. Davidson, Gregory W. Barsness, David M. Shavelle, Martin Cohen, Joseph Poole, Thomas Moss, Pamela Hyde, Anna Maria Kanakaraj, Vitaly DrukerAmy Chung, Candice Junge, Robert A. Preti, Robin L. Smith, David J. Mazzo, Andrew Pecora, Douglas W. Losordo

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint Dive into the research topics of 'PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients with Left Ventricular Dysfunction Post STEMI'. Together they form a unique fingerprint.

Medicine & Life Sciences